Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Pharmacokinetic profiles of two oral AII antagonists described by Pfizer at AAPS

Nov. 18, 1999

AVI BioPharma files IND with FDA for Resten-NG

Nov. 18, 1999

Cardiovascular and renal agents from SB act as endothelin antagonists

Nov. 16, 1999

Cardioprotective ginkgolides under study at CNRS

Nov. 16, 1999

Favorable phase II results announced for Valentis's VEGF165 gene medicine at AHA

Nov. 15, 1999

Mechanism of antioxidant action of S-17834 explored in vitro

Nov. 15, 1999

AstraZeneca's immunomodulator H-327/86 is a novel candidate for treating atherosclerosis

Nov. 15, 1999

United Therapeutics completes enrollment in phase III pulmonary hypertension trial

Nov. 12, 1999

Synergistic effects Na+/H+ exchange inhibitor and K(ATP) channel opener in MI

Nov. 11, 1999

ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...